Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin in Patients with Early-Onset Ventilator-Associated Pneumonia

Author： Pea F.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.42, Iss.6, 2003-01, pp. : 589-598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ventilator-associated pneumonia: an overview

By DiCocco Jennifer M   Croce Martin A  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1461-1467

Informa Healthcare

Access to resources Recommend Favorite

Early and potent antibacterial therapy is central to effective management of ventilator-associated pneumonia

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 2, 2007-02 ,pp. : 11-13

Adis International

Access to resources Recommend Favorite

Early intervention with empirical antibacterials is essential in the treatment of ventilator-associated pneumonia

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 6, 2011-06 ,pp. : 9-12

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Levofloxacin in Intensive Care Patients

By Navarro Amparo Sánchez  

Clinical Pharmacokinetics, Vol. 44, Iss. 6, 2005-01 ,pp. : 627-635

Adis International

Access to resources Recommend Favorite

Resolution of Chest X-Ray Opacities in Patients with Ventilator-associated Pneumonia

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 18, Iss. 1, 2018-03 ,pp. : 23-28

Bentham Science Publishers

Access to resources Recommend Favorite